Jorge Capurro

As Director of Drug Delivery Devices at Archimedic, Jorge leads the development of injectors, infusion pumps, and novel drug delivery devices.

Jorge has been involved in medical devices and drug delivery since 2005.  As Director of Drug Delivery Devices, he leads teams in to achieve technical, regulatory, and commercial milestones.

He started his drug delivery journey in the academic setting during graduate studies at Drexel University.  His research involved the use of applied AC/DC electric fields to manipulate particles and fluids.  This effort led to the design and manufacturing of microfluidic devices (Lab-on-a-Chip) with potential applications in drug delivery and diagnostics.

In 2010, he began his professional career at Johnson & Johnson (J&J - Animas Corporation) with the exploration, design and prototyping of medical devices for accurate and precise drug delivery.  He has developed unique methods to measure and analyze dose accuracy and precision to differentiate the performance of insulin pumps.  He has authored publications and presented findings at international conferences.

While at J&J, he led product development activities with the design verification and validation of the Animas Vibe CGM-Enable insulin pump, leading to the PMA regulatory approval and commercialization.   He also led internal and external cross-functional teams in product development, manufacturing, test equipment development, and tech transfer activities of a connected Artificial Pancreas system (next generation product) which included an insulin pump, CGM sensor and Off Device software.  In addition, he supported development efforts of a dual delivery system for macular degeneration applications and medical device solutions for pain relief.

In 2018, he joined Takeda Pharmaceuticals to lead the development of an on-body electromechanical combination product for immunoglobulin therapy drug delivery.  He has led a range of internal and external cross-functional teams in the development of primary packaging, vial access devices, electromechanical infusion pumps, administration sets, in-line warmers, sensory devices, and needle sets for the administration of viscous fluids required for clinical trials and commercialization in global regions.  He has a deep understanding of device development (developed a device development process) in a pharmaceutical setting, device regulatory strategy for clinical trials and commercialization, innovation strategy, market access strategy, and program and stakeholder management.

Jorge holds a B.S and M.S in Mechanical Engineering and Mechanics from Drexel University.